Huons Co., Ltd. (KOSDAQ:243070)
25,850
+500 (1.97%)
Apr 10, 2026, 3:30 PM KST
Huons Revenue
In the year 2025, Huons had annual revenue of 620.77B KRW with 5.17% growth. Huons had revenue of 165.19B in the quarter ending December 31, 2025, with 12.66% growth.
Revenue
620.77B
Revenue Growth
+5.17%
P/S Ratio
0.48
Revenue / Employee
680.67M
Employees
912
Market Cap
295.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.77B | 30.54B | 5.17% |
| Dec 31, 2024 | 590.23B | 38.22B | 6.92% |
| Dec 31, 2023 | 552.01B | 59.62B | 12.11% |
| Dec 31, 2022 | 492.39B | 55.48B | 12.70% |
| Dec 31, 2021 | 436.91B | 30.23B | 7.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Holdings | 969.57B |
| Chong Kun Dang Holdings | 959.01B |
| Samjin Pharmaceuticals | 274.03B |
| HLB Pharmaceutical | 205.58B |
| Boditech Med | 162.09B |
| Korea United Pharm | 161.44B |
| Yungjin Pharm. | 158.79B |
| Humedix | 110.99B |